European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading

European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.61% to 1,415.12 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion Biotech (EVAX) and telecommunications operator Telefonica (TEF), which rose 2% and 1.8%, respectively. They were followed by biopharmaceutical company Calliditas Therapeutics (CALT) and internet advertising firm Criteo (CRTO), which were up 0.8% each.

The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which fell 4.8% and 3.4%, respectively. They were followed by biopharmaceutical companies Cellectis (CLLS) and MorphoSys (MOR), which were down 3.1% and 2.8%, respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech (TRIB) and cruise line operator Carnival (CUK), which increased 6.8% and 5.6%, respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and electricity and gas provider National Grid (NGG), which were up 3.6% and 1.9%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Amarin (AMRN) and Adaptimmune Therapeutics (ADAP), which lost 10% and 6.5%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and mining company BHP Group (BHP), which dropped 5.6% and 3.1%, respectively.